Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „duration“
Suchtreffer
Begriffe & Kennungen
Ibrance · 4.8 · Table 4 reports the adverse reactions from the pooled dataset of 3 randomised studies. The median duration of
Eintrag öffnenIbrance · 4.8 · The median time to first episode of any grade neutropenia was 15 days (12-700 days) and the median duration of
Eintrag öffnenIbrance · 4.8 · The median time to first episode of any grade neutropenia was 15 days (12-700 days) and the median duration of
Eintrag öffnenIdacio · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenIdacio · 4.8 · In controlled Phase 3 trials of adalimumab in patients with plaque psoriasis with a control period duration ra
Eintrag öffnenImatinib Teva · 4.8 · 15 (platelet count < 10 x 109/l) were observed in 3.6% and < 1% of patients, respectively. The median duration
Eintrag öffnenImraldi · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenImraldi · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenImraldi · 4.8 · During the controlled portions of pivotal adalimumab trials in adults of at least 12 weeks in duration in pati
Eintrag öffnenImraldi · 4.8 · In controlled Phase 3 trials of adalimumab in patients with plaque psoriasis with a control period duration ra
Eintrag öffnenImraldi · 4.8 · In controlled Phase 3 trials of adalimumab in patients with plaque psoriasis with a control period duration ra
Eintrag öffnenImraldi · 4.8 · In controlled Phase 3 trials of adalimumab in patients with plaque psoriasis with a control period duration ra
Eintrag öffnenIzba · 4.8 · In a clinical trial of 3 months duration (N=442) involving IZBA as monotherapy, the most common adverse reacti
Eintrag öffnenJalra · 4.8 · 5 discontinuations. No association was found between adverse reactions and age, ethnicity, duration of exposur
Eintrag öffnenJardiance · 4.8 · In 6 placebo-controlled trials of 18 to 24 weeks duration, 3 534 patients were included of which 1 183
Eintrag öffnenJivi · 4.8 · Overall, in all studies 75 patients, 39 of them below 12 years of age, were observed for a treatment duration
Eintrag öffnenKisqali · 4.8 · The median duration of exposure to ribociclib across the study was 33.0 months, with 69.4% patients exposed fo
Eintrag öffnenKisqali · 4.8 · The median duration of exposure to study treatment across the pooled phase III studies dataset was 19.2 months
Eintrag öffnenKorjuny · 4.8 · 9 Duration of infusion Data on a 3-hour infusion duration of catumaxomab are available from studies in maligna
Eintrag öffnenKoselugo · 4.8 · In the SPRINKLE study, at the time of first data cut-off (DCO1), the median total duration of selumetinib trea
Eintrag öffnen